Clinical trial · Interventional
Mid-point Transverse Process to Pleura Block for Breast Cancer Surgery: A Randomized Controlled Trial
Analgesic Benefits of the Novel Mid-point Transverse Process to Pleura (MTP) Block for Ambulatory Breast Cancer Surgery: A Randomized Controlled Trial
NCT03713255CI-TRIAL-00061182unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will compare the analgesic effects of midpoint transverse process to pleura (MTP) block to control as well as thoracic paravertebral block.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Pain | — | UNRESOLVED | — |
| Anesthesia | — | UNRESOLVED | — |
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Control Group | Procedure | — | UNRESOLVED |
| MTP block group | Procedure | — | UNRESOLVED |
| PVB group | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- PVB group
- description
- paravertebral blocks with 0.5% ropivacaine and epinephrine 2.5 mcg/mL
- interventionNames
- Procedure: PVB group
- type
- EXPERIMENTAL
- label
- MTP block group
- description
- MTP blocks with 0.5% ropivacaine and epinephrine 2.5 mcg/mL
- interventionNames
- Procedure: MTP block group
- type
- SHAM_COMPARATOR
- label
- control group
- description
- local anesthetic infiltration subcutaneous 1% lidocaine
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * English or French Speaking * Scheduled for major breast surgery * ASA physical status classification I-III * BMI \<30kg/m2 Exclusion Criteria: * Prior ipsilateral breast surgery * Pre-existing neurological deficit or peripheral neuropathy involving the ipsilateral chest * Contraindications to regional anesthesia * Patient refusal of regional technique * Chronic pain disorder * Chronic opioid use * Inability to provide informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.